Sort
23,748 grants matching “melanoma”
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$375,350Andrew E Aplin · Wistar Institute · P01 · FY2021 · CA
Strategies for Receptor inhibition in immunotherapy
$375,318Kenan Christopher Garcia · Stanford University · R01 · FY2025 · CA
Gene regulatory network controlling neural crest derived formation of facial cartilage
$375,291Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2024 · DE
Molecular connections among UV exposure, red hair, nevi and melanoma
$375,227Rutao Cui · Boston University Medical Campus · R01 · FY2016 · CA
Cellular Mechanisms of Therapy Resistance in Melanoma
$375,217Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
UV INDUCIBLE INHIBITION IN MELANOMA
$375,214Burnham Institute For Medical Research · R01 · FY2005 · CA
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$375,159Jeffrey K Harrison · University Of Florida · R01 · FY2018 · NS
Development of murine glioblastoma model for oncolytic HSV therapy
$375,155Balveen Kaur · Augusta University · R61 · FY2025 · NS
Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer Management
$375,150Saeed Hassanpour · Dartmouth College · R01 · FY2020 · CA
Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer Management
$375,150Saeed Hassanpour · Dartmouth College · R01 · FY2019 · CA
Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer Management
$375,150Saeed Hassanpour · Dartmouth College · R01 · FY2021 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$375,150Bo Li · Ut Southwestern Medical Center · R01 · FY2022 · CA
Dietary trans-vaccenic acid enhances anti-tumor immunity
$375,150Jing Chen · University Of Chicago · R01 · FY2025 · CA
Dietary trans-vaccenic acid enhances anti-tumor immunity
$375,150Jing Chen · University Of Chicago · R01 · FY2023 · CA
Diagnosis of Clinically Early Melanomas
$375,149Meenhard Herlyn · Wistar Institute · P50 · FY2007 · CA
Role of p21-activated kinases in thyroid cancer
$375,129Matthew D Ringel · Ohio State University · R01 · FY2021 · CA
Role of p21-activated kinases in thyroid cancer
$375,129Matthew D Ringel · Ohio State University · R01 · FY2020 · CA
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$375,106Andrew E Aplin · Wistar Institute · P01 · FY2019 · CA
Cell Surface Lectins and Intercellular Adhesion
$375,049Steven D Rosen · University Of California, San Francisco · R01 · FY2008 · GM
Cell Surface Lectins and Intercellular Adhesion
$375,049Steven D Rosen · University Of California, San Francisco · R01 · FY2009 · GM
Structure and Function of T Cell Antigen Receptors
$375,000Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2010 · AI
Prospective validation of a radiomics-based multi-modal predictive model for metastatic non-small cell lung cancer patients treated with PD-1 immunotherapy
$375,000Petr Jordan · Onc.Ai, Inc. · R44 · FY2025 · CA
FAI: Towards Holistic Bias Mitigation in Computer Vision Systems
$375,000Nuno M Vasconcelos · University Of California-San Diego · · FY2021 · CSE
Mechanisms of Immune Evasion by Ocular Tumors
$374,963Kyle C McKenna · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · EY
Cancer and Leukemia Group B - The Ohio State University
$374,894Clara D Bloomfield · Ohio State University · U10 · FY2006 · CA